A switch-on mechanism to activate maize ribosome-inactivating protein for targeting HIV-infected cells

Nucleic Acids Res. 2010 Oct;38(19):6803-12. doi: 10.1093/nar/gkq551. Epub 2010 Jun 17.

Abstract

Maize ribosome-inactivating protein (RIP) is a plant toxin that inactivates eukaryotic ribosomes by depurinating a specific adenine residue at the α-sarcin/ricin loop of 28S rRNA. Maize RIP is first produced as a proenzyme with a 25-amino acid internal inactivation region on the protein surface. During germination, proteolytic removal of this internal inactivation region generates the active heterodimeric maize RIP with full N-glycosidase activity. This naturally occurring switch-on mechanism provides an opportunity for targeting the cytotoxin to pathogen-infected cells. Here, we report the addition of HIV-1 protease recognition sequences to the internal inactivation region and the activation of the maize RIP variants by HIV-1 protease in vitro and in HIV-infected cells. Among the variants generated, two were cleaved efficiently by HIV-1 protease. The HIV-1 protease-activated variants showed enhanced N-glycosidase activity in vivo as compared to their un-activated counterparts. They also possessed potent inhibitory effect on p24 antigen production in human T cells infected by two HIV-1 strains. This switch-on strategy for activating the enzymatic activity of maize RIP in target cells provides a platform for combating pathogens with a specific protease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Anti-HIV Agents / chemistry*
  • Anti-HIV Agents / metabolism
  • Anti-HIV Agents / pharmacology
  • Cell Line
  • Enzyme Activation
  • HIV Protease / metabolism
  • HIV-1 / physiology
  • Humans
  • Molecular Sequence Data
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / metabolism
  • Ribosome Inactivating Proteins / genetics*
  • Ribosome Inactivating Proteins / metabolism
  • Ribosome Inactivating Proteins / pharmacology*
  • T-Lymphocytes / virology
  • Zea mays / enzymology
  • tat Gene Products, Human Immunodeficiency Virus / genetics

Substances

  • Anti-HIV Agents
  • Recombinant Fusion Proteins
  • tat Gene Products, Human Immunodeficiency Virus
  • Ribosome Inactivating Proteins
  • HIV Protease
  • p16 protease, Human immunodeficiency virus 1